TOVX icon

Theriva Biologics
TOVX

Overview Fund Trends Analyst Outlook Journalist POV

9 hedge funds and large institutions have $60.3K invested in Theriva Biologics in 2024 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less ownership

Funds ownership: →

less funds holding

Funds holding: →

less first-time investments, than exits

New positions opened: | Existing positions closed:

91% less capital invested

Capital invested by funds: $679K → $60.3K (-$619K)

Holders
9
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$13.6K
2
+$1.28K
3
+$19

Top Sellers

1
-$196K
2
-$192K
3
-$138K
4
MP
MSD Partners
New York
-$37.7K
5
Morgan Stanley
Morgan Stanley
New York
-$27.9K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$28.7K
2
$13.6K
3
$13.2K
4
$2.44K
5
$2.26K
6
$35
7
$25
8
$19
9
$18
10
–
11
–
12
–
13
–
14
–
15
–
16
–
17
–
18
–